Michel Vounatsos - Jan 19, 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Executive Officer, Director
Signature
/s/ Wendell Taylor, attorney-in-fact for Michel Vounatsos
Stock symbol
BIIB
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/21/2022, 03:45 PM
Previous filing
May 10, 2021
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Award $0 +10.6K +19.96% $0.00 63.7K Jan 19, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022.
F2 Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021.